FATE (Fate Therapeutics, Inc.) Pangali Forward P/E
This price chart for Fate Therapeutics, Inc. (FATE) demonstrates the 0.00 metric. The asset's price action depends on the outcomes of tests for new tumor-fighting methods. The business is based on creating advanced cell-based therapies for immune pathologies and cancer. Fate Therapeutics, Inc. (FATE) raises funds through grants and payments from major pharma partners, which helps contain R&D costs.
Ringkesan rincian data analitis Fate Therapeutics, Inc. (FATE)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Fate Therapeutics, Inc.|FATE - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Fate Therapeutics, Inc.|FATE - Gunggung tanggungan utang perusahaan|Utang-utang marang kapitalisasi buku Fate Therapeutics Corp|FATE - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Fate Therapeutics|Rasio cepet fatetherapeutics.com
- rincian asil keuangan lan kelipatan valuasi:
FATE - Penghasilan resik perusahaan|Bathi mangsa ngarep Fate Therapeutics, Inc.|FATE - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Fate Therapeutics Corp|FATE - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Fate Therapeutics|FATE - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Fate Therapeutics|FATE - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan fatetherapeutics.com|FATE - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Fate Therapeutics, Inc.
- indikator volume dodolan lan pendapatan:
Pambiji fundamental perusahaan:Fate Therapeutics Inc
As a portfolio manager, I utilize this tool to gauge market expectations. The metric compares the current quote with projected net income, measuring the cost of one dollar of future earnings. By analyzing the forward P/E ratio of a company, an investor determines the asset's degree of overbought status. For Fate Therapeutics, Inc. (FATE), this indicator is critical, as it reflects market confidence in the success of costly clinical trials. High volatility in the line confirms that capitalization depends on the rate of liquidity burn.
Analisis perusahaan pesaing
Pangali Forward P/E ONC|HALO (Halozyme Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (revmed.com)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Bio (BCAX) - Rega marang bathi mangsa ngarep|Personalis Corp - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Inc) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Systems, Inc. DCTH|Prakiraan rega marang bathi YMAB (Y-mAbs Corp)|Pangali Forward P/E Aura Bio (AURA)|Pangali Forward P/E CADL (Candel Therapeutics Inc.)|ARAY - Prakiraan rega marang bathi|SLS - Rega marang bathi mangsa ngarep|Actuate Therapeutics - Rasio kapitalisasi marang bathi mangsa ngarep|CTOR: Pangali Forward P/E|TuHURA (HURA) - Pangali Forward P/E|TARA (Protara Therapeutics Inc) - Pangali Forward P/E|WHWK: Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi TCRX (TScan Therapeutics Inc)|Kapitalisasi marang proyeksi bathi Champions Oncology Inc|Pangali Forward P/E XBIT (XBiotech Inc.)|Pangali mangsa ngarep rega marang bathi CVM|OS Therapies Inc. - Pangali Forward P/E|RADX - Pangali Forward P/E|ARTV: Pangali Forward P/E|ANL: Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi VERU|TPST: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep xiliotx.com (XLO)|Renovaro - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Mural Oncology MURA|KAPA - Prakiraan rega marang bathi|OKUR - Rega marang bathi mangsa ngarep|GDTC - Pangali Forward P/E|Curis, Inc. (CRIS) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Apollomics, Inc.|Prakiraan rega marang bathi THAR|Rasio rega marang bathi mangsa ngarep ADVB (Advanced Biomed)|Prakiraan rega marang bathi GNPX (Genprex, Inc)|CLDI: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep sunshinebiopharma.com SBFM|XBIO - Prakiraan rega marang bathi|SLRX: Prakiraan rega marang bathi|Purple Biotech - Rasio kapitalisasi marang bathi mangsa ngarep|American Oncology Network (AONC) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep BGNE|Prakiraan rega marang bathi CKPT|Rega marang bathi mangsa ngarep ELEV|Pangali Forward P/E ICAD|Pangali Forward P/E Ikena Oncology Inc. (IKNA)|Pangali Forward P/E NTBL (Notable Labs Ltd)|Kapitalisasi marang proyeksi bathi Viracta Therapeutics (VIRX)|MOR: Prakiraan rega marang bathi|NAYA (NAYA Bio) - Rasio rega marang bathi mangsa ngarep|AAPGV: Pangali Forward P/E
